When will Compass Pathways submit a NDA for COMP360 psilocybin?
As of Tue, 20 Oct 2026 11:11:57 UTC, Kalshi traders price before April 2027 (84.0%), before 2027 (72.0%), before December (51.0%). The market has $31K in volume and closes on Thu, 01 Apr 2027.
Updated:
Current odds
| Outcome | Chance | Yes price | No price |
|---|---|---|---|
| before April 2027 | 84.0% | 84.0¢ | 16.0¢ |
| before 2027 | 72.0% | 72.0¢ | 28.0¢ |
| before December | 51.0% | 51.0¢ | 49.0¢ |
| before November | 14.0% | 14.0¢ | 86.0¢ |
| before October | 3.0% | 3.0¢ | 97.0¢ |
Market details
- Venue: Kalshi
- Volume: $31K
- Liquidity: $31K
- Closes:
Resolution rules
Each outcome is a separate contract with its own rules. The rules for before April 2027:
If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Apr 1, 2027, then the market resolves to Yes.
Sources
Related markets
- When will the FDA reclassify BPC-157 to Category 1?
- Will the U.S. confirm that aliens exist?
- Best AI at the end of 2026?
- When will Anthropic release Mythos?
- Will WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- Measles cases this year?
DOXA is a liquidity aggregator for prediction markets that compares odds and depth across Polymarket, Kalshi and others and routes each trade for best execution with an AI assistant.